HD
32
-2
CLX
51
-2
XRX
38
-3
ORCL
26
2
LYB
20
-3
WM
57
-2
PLD
28
-2
CHRW
79
3
DGX
33
-3
MCHP
55
5
VNO
50
-2
AVY
54
-7
PHM
43
-3
BIIB
46
-3
LOW
67
18
LB
31
-2
JBHT
63
3
AON
67
2
FDX
61
11
TRIP
47
-5
HD
32
-2
CLX
51
-2
XRX
38
-3
ORCL
26
2
LYB
20
-3
WM
57
-2
PLD
28
-2
CHRW
79
3
DGX
33
-3
MCHP
55
5
VNO
50
-2
AVY
54
-7
PHM
43
-3
BIIB
46
-3
LOW
67
18
LB
31
-2
JBHT
63
3
AON
67
2
FDX
61
11
TRIP
47
-5
Financhill
Back

ACADIA Pharmaceuticals, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
55

ACAD
ACADIA Pharmaceuticals, Inc.

Last Price:
$27.16
Seasonality Move:
14.5%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
55
ACADIA Pharmaceuticals, Inc. (ACAD) is a Buy

Is ACADIA Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals, Inc. [ACAD] share price is $27.16. The Score for ACAD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ACAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals, Inc.'s stock price today?

  • The ACADIA Pharmaceuticals, Inc. share price today is $27.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAD is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.94 Buy
Relative Strength Index (14 RSI): 65.23 Buy
Chaikin Money Flow: 885219 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.09 - 27.01) Buy
Bollinger Bands (100): (21.91 - 25.81) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -36886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.92 Buy
20-day SMA: 26.04 Buy
50-day SMA: 23.76 Buy
200-day SMA: 21.47 Buy
8-day EMA: 26.83 Buy
20-day EMA: 26.05 Buy
50-day EMA: 24.66 Buy
200-day EMA: 22.18 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.2 Sell
20-day SMA: 79.37 Sell
50-day SMA: 82.12 Sell
200-day SMA: 52.13 Buy
8-day EMA: 72.25 Sell
20-day EMA: 76.67 Sell
50-day EMA: 77.13 Sell
200-day EMA: 56.56 Buy

ACADIA Pharmaceuticals, Inc. Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.01 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

ACADIA Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):